Home › Eczema › Arizona › Phoenix
Eczema clinical trials in Phoenix, AZ
4 studies for Eczema are looking for participants at sites in and around Phoenix (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
RecruitingPhase 2
- Mayo Clinic Hospital, Phoenix
- Mayo Clinic Specialty Building, Phoenix
Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
RecruitingObservational study
- U.S. Dermatology Partners, Phoenix
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
- Saguaro Dermatology Associates, Phoenix
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
RecruitingPhase 2
- Medical Dermatology Specialists, Phoenix
- Onyx Clinical Research, Phoenix
About Eczema
Eczema is a general term for different types of rashes. Atopic dermatitis, the most common type, is an allergic skin reaction. Read about treatments.
More about Eczema on MedlinePlus
Eczema trials in other cities
- San Antonio, TX7 studies
- Birmingham, AL6 studies
- Indianapolis, IN5 studies
- New York City, NY5 studies
- Los Angeles, CA5 studies
- San Diego, CA5 studies
- Miami, FL4 studies
- Santa Clarita, CA4 studies
- Pittsburgh, PA4 studies
- Huntington Beach, CA4 studies
- Washington, DC4 studies
- San Francisco, CA3 studies
Other studies in Phoenix
- Breast Cancer25 studies
- Colorectal Cancer25 studies
- Obesity22 studies
- Non-Small Cell Lung Cancer20 studies
- Metastatic Cancer20 studies
- Heart Failure18 studies
- Prostate Cancer17 studies
- Cancer (all types)17 studies
- Multiple Myeloma16 studies
- Pancreatic Cancer16 studies
- Cardiovascular Disease16 studies
- Alzheimer's Disease15 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.